Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuronetics (STIM) Operating Expenses (2017 - 2025)

Historic Operating Expenses for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $24.4 million.

  • Neuronetics' Operating Expenses rose 1242.58% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.4 million, marking a year-over-year increase of 2519.62%. This contributed to the annual value of $88.7 million for FY2024, which is 785.93% up from last year.
  • Neuronetics' Operating Expenses amounted to $24.4 million in Q3 2025, which was up 1242.58% from $25.8 million recorded in Q2 2025.
  • In the past 5 years, Neuronetics' Operating Expenses ranged from a high of $26.8 million in Q1 2025 and a low of $17.0 million during Q1 2021
  • In the last 5 years, Neuronetics' Operating Expenses had a median value of $20.7 million in 2024 and averaged $21.3 million.
  • Examining YoY changes over the last 5 years, Neuronetics' Operating Expenses showed a top increase of 4602.54% in 2021 and a maximum decrease of 1079.82% in 2021.
  • Quarter analysis of 5 years shows Neuronetics' Operating Expenses stood at $18.4 million in 2021, then rose by 17.08% to $21.5 million in 2022, then dropped by 6.21% to $20.2 million in 2023, then skyrocketed by 30.53% to $26.4 million in 2024, then dropped by 7.34% to $24.4 million in 2025.
  • Its Operating Expenses stands at $24.4 million for Q3 2025, versus $25.8 million for Q2 2025 and $26.8 million for Q1 2025.